A detailed history of Hsbc Holdings PLC transactions in Stereotaxis, Inc. stock. As of the latest transaction made, Hsbc Holdings PLC holds 68,606 shares of STXS stock, worth $151,619. This represents 0.0% of its overall portfolio holdings.

Number of Shares
68,606
Previous 41,547 65.13%
Holding current value
$151,619
Previous $88,000 137.5%
% of portfolio
0.0%
Previous 0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 13, 2025

BUY
$2.14 - $3.06 $57,906 - $82,800
27,059 Added 65.13%
68,606 $209,000
Q2 2025

Aug 13, 2025

SELL
$1.6 - $2.37 $1,585 - $2,348
-991 Reduced 2.33%
41,547 $88,000
Q1 2025

May 14, 2025

SELL
$1.76 - $2.64 $75 - $113
-43 Reduced 0.1%
42,538 $74,000
Q4 2024

Feb 14, 2025

BUY
$1.84 - $2.47 $39,675 - $53,260
21,563 Added 102.59%
42,581 $97,000
Q3 2024

Nov 14, 2024

BUY
$1.76 - $2.35 $36,991 - $49,392
21,018 New
21,018 $42,000

Others Institutions Holding STXS

About Stereotaxis, Inc.


  • Ticker STXS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 74,790,096
  • Market Cap $165M
  • Description
  • Stereotaxis, Inc. designs, manufactures, and markets robotic systems, instruments, and information systems for the interventional laboratory in the United States and internationally. Its robotic magnetic navigation (RMN) systems include the Genesis RMN and Niobe systems, which enable physicians to complete complex interventional procedures by pr...
More about STXS
Track This Portfolio

Track Hsbc Holdings PLC Portfolio

Follow Hsbc Holdings PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hsbc Holdings PLC, based on Form 13F filings with the SEC.

News

Stay updated on Hsbc Holdings PLC with notifications on news.